Literature DB >> 24446563

Behavioral and language variants of frontotemporal dementia: a review of key symptoms.

Robert Laforce.   

Abstract

While recent advances in the development of neuroimaging and molecular biomarkers for studying neurodegenerative conditions have revolutionized the field, dementia remains a clinical diagnosis. No component of the diagnostic process is more crucial than obtaining a good history. Getting to know the first manifestations of the disease, tracking their evolution and functional impact, combined with a targeted neurological examination, further guides differential diagnosis. This paper summarizes the key symptoms of the behavioral and language variants of frontotemporal dementia. The behavioral variant of frontotemporal dementia (bvFTD) is characterized by severe changes in behavior and personality such as disinhibition, apathy, loss of empathy, or stereotypic behavior, leading to a loss of social competence. Executive functions are impaired, while memory and visuospatial skills are relatively better preserved. By contrast, the language variants or primary progressive aphasias (PPAs) are marked by prominent language disturbances that can be subclassified into a non-fluent/agrammatic variant (naPPA), a semantic variant (svPPA), and a logopenic variant (lvPPA). Although combined characterization of clinical, imaging, biological and genetic biomarkers is essential to establish a detailed diagnosis of such heterogeneous conditions, the author emphasizes the importance of accurate recognition of key symptoms that can lead to better identification of underlying neuropathology and appropriate treatment approaches.

Entities:  

Mesh:

Year:  2013        PMID: 24446563     DOI: 10.1016/j.clineuro.2013.09.031

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  7 in total

Review 1.  FDG-PET Contributions to the Pathophysiology of Memory Impairment.

Authors:  Shailendra Segobin; Renaud La Joie; Ludivine Ritz; Hélène Beaunieux; Béatrice Desgranges; Gaël Chételat; Anne Lise Pitel; Francis Eustache
Journal:  Neuropsychol Rev       Date:  2015-08-30       Impact factor: 7.444

2.  Clinical and genetic analyses of familial and sporadic frontotemporal dementia patients in Southern Italy.

Authors:  Rosa Capozzo; Celeste Sassi; Monia B Hammer; Simona Arcuti; Chiara Zecca; Maria R Barulli; Rosanna Tortelli; J Raphael Gibbs; Cynthia Crews; Davide Seripa; Francesco Carnicella; Claudia Dell'Aquila; Marco Rossi; Filippo Tamma; Francesco Valluzzi; Bruno Brancasi; Francesco Panza; Andrew B Singleton; Giancarlo Logroscino
Journal:  Alzheimers Dement       Date:  2017-03-03       Impact factor: 21.566

3.  Frontotemporal dementia patients exhibit deficits in predictive saccades.

Authors:  Nicolas Deravet; Jean-Jacques Orban de Xivry; Adrian Ivanoiu; Jean-Christophe Bier; Kurt Segers; Demet Yüksel; Philippe Lefèvre
Journal:  J Comput Neurosci       Date:  2020-09-18       Impact factor: 1.621

Review 4.  Neuropalliative Care: A Practical Guide for the Neurologist.

Authors:  K Brizzi; C J Creutzfeldt
Journal:  Semin Neurol       Date:  2018-10-15       Impact factor: 3.420

5.  Early Cognitive/Social Deficits and Late Motor Phenotype in Conditional Wild-Type TDP-43 Transgenic Mice.

Authors:  Julio A Alfieri; Pablo R Silva; Lionel M Igaz
Journal:  Front Aging Neurosci       Date:  2016-12-20       Impact factor: 5.750

6.  Memory Test Performance on Analogous Verbal and Nonverbal Memory Tests in Patients with Frontotemporal Dementia and Alzheimer's Disease.

Authors:  Deanna Baldock; Justin B Miller; Gabriel C Leger; Sarah Jane Banks
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2016-01-19

7.  Depressive Symptom Profiles Predict Specific Neurodegenerative Disease Syndromes in Early Stages.

Authors:  Suzanne M Shdo; Kamalini G Ranasinghe; Virginia E Sturm; Katherine L Possin; Brianne M Bettcher; Melanie L Stephens; Jessica M Foley; Shou-Chin Christine You; Howard J Rosen; Bruce L Miller; Joel H Kramer; Katherine P Rankin
Journal:  Front Neurol       Date:  2020-05-29       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.